The 20 Best Pancreatic Islet Cell Tumor Doctors Near Me in New York, NY

Edward Wolin is an Oncologist practicing medicine in New York, New York. Dr. Wolin is rated as an Elite provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Liver Embolization, and Endoscopy.

Nitya Raj is an Oncologist practicing medicine in New York, New York. Dr. Raj is rated as an Elite provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Adrenocortical Carcinoma, Liver Embolization, and Endoscopy. Dr. Raj is currently accepting new patients.

Christopher Wolfgang is a General Surgeon practicing medicine in New York, New York. Dr. Wolfgang is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

"Matthew J. Weiss, MD, FACS, is deputy physician-in-chief and director of the surgical oncology program at Northwell Cancer Institute. He's a board-certified surgeon specializing in pancreas and liver diseases.With a relentless work ethic and strong desire to help people, Dr. Weiss always knew he wanted to be a doctor. ""I picked a field that allows me to tackle difficult problems and truly make an impact,"" he says.Dr. Weiss completed his residency in general surgery at Johns Hopkins Hospital and was dual fellowship trained in surgical oncology and hepatobiliary surgery at Memorial Sloan-Kettering Cancer Center. He was previously chief of hepatobiliary surgery at Johns Hopkins, where he was also director of the Pancreas and Liver Multidisciplinary Clinics and the complex general surgical oncology fellowship. He also performed the first robotic Whipple at Johns Hopkins University. Joining Northwell in 2019, Dr. Weiss created a multidisciplinary team of surgeons, medical and radiation oncologists, geneticists, and other specialists who collaborate to create unique treatment plans for patients across the health system. ""Every cancer is different, and every patient is different,"" he says. ""Communication among multiple providers is the best way to ensure you're treating the entire person, properly,"" he says. Dr. Weiss's team also works with scientists from Cold Spring Harbor Laboratory and Feinstein Institutes for Medical Research to develop and run groundbreaking clinical trials. An international leader in both liver and pancreas surgery, Dr. Weiss has authored over 250 peer-reviewed publications in the field, and he's currently a professor of surgery and oncology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. ""Understanding both the science of the disease and the technological aspect of surgery is so important,"" he says. Dr. Weiss focuses on using cancer genetics to help find the right surgical approach for patients. When possible, he operates robotically using small incisions for faster healing, so patients don't have to wait as long to receive additional therapies that can improve outcomes. With recent advancements in the field, Dr. Weiss has been able to successfully perform high-risk surgeries that were turned down by other institutions. ""Being a surgeon is a tremendous responsibility, and I don't take it lightly,"" he says. ""I truly and deeply care about my patients and their families-I get to know them as people and am there throughout their entire journey. That's what I'm most proud of as a doctor.""". Dr. Weiss is rated as an Advanced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Hepatectomy. Dr. Weiss is board certified in American Board Of Surgery.

Dr. Charles M. Noyer is the Chief of Gastroenterology at White Plains Hospital. Board-certified in Internal Medicine and Gastroenterology, he is an expert in all gastroenterology disorders and is one of the few doctors in the region to perform endoscopic ultrasounds. Dr. Noyer is rated as an Advanced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Insulinoma, Glucagonoma, Endoscopy, and Pancreatectomy. Dr. Noyer is board certified in American Board Of IM/Gastroenterology.

Renuka Iyer is an Oncologist practicing medicine in Buffalo, New York. Dr. Iyer is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreatic Islet Cell Tumor, and Tissue Biopsy.

Naris Nilubol is a General Surgeon practicing medicine in Astoria, New York. Dr. Nilubol is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pheochromocytoma, Adrenal Cancer, Parathyroidectomy, and Pancreaticoduodenectomy.

William Jarnagin is a General Surgeon practicing medicine in New York, New York. Dr. Jarnagin is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Gallbladder Cancer, Hepatectomy, and Pancreatectomy. Dr. Jarnagin is currently accepting new patients.

John Chabot is an Oncologist practicing medicine in New York, New York. Dr. Chabot is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Chabot is currently accepting new patients.

Michael D'angelica is a General Surgeon and a Surgical Oncologist practicing medicine in New York, New York. Dr. D'angelica is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Colorectal Cancer, Hepatectomy, and Pancreatectomy. Dr. D'angelica is currently accepting new patients.

Thomas Fahey is a General Surgeon practicing medicine in New York, New York. Dr. Fahey is rated as an Advanced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Anaplastic Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

Joshua Raff, M.D. is the Director of the Digestive Cancer Program at White Plains Hospital, as well as the Leader of the Hospital's GI Cancer Program Conference. Dr. Raff received his medical degree from the Sackler School of Medicine at Tel Aviv University in 1997. He completed his residency in internal medicine at Montefiore Medical Center in the Bronx, and was a fellow of hematology and oncology at Albert Einstein College of Medicine from 2000-2003. Dr. Raff is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), and Familial Pancreatic Cancer. Dr. Raff is board certified in American Board Of Internal Medicine.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Vinciguerra is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

John C. McAuliffe, MD, PhD, FACS, is a Surgical Oncologist at Montefiore and an Associate Professor at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2016, his clinical focus has been on endocrine, neuroendocrine, and pancreaticobiliary benign and malignant diseases. In 2000, Dr. McAuliffe received his Bachelor of Arts in Biochemistry at Baylor University. Following this, he received his Doctor of Philosophy in 2007 at the University of Texas Graduate School of Biomedical Sciences at Houston. He attended the McGovern Medical School in Houston, where he received his Doctor of Medicine in 2009. Dr. McAuliffe began his postgraduate training in 2007 with a year-long fellowship at the University of Texas MD Anderson Cancer Center. Following this, he trained at the University of Alabama-Birmingham Hospital from 2009 to 2014. While there, he completed an internship and residency in General Surgery, becoming Administrative Chief Resident in his final year. He then completed a fellowship in Complex General Surgical Oncology at Memorial Sloan-Kettering Cancer Center in 2016. Dr. McAuliffe’s research focuses on tumor biology, dissemination, and therapeutics in pancreatic adenocarcinoma via tumor-associated macrophages. He is also the Associate Program Director of Montefiore General Surgery Residency and Site Director for the medical student clerkships for the Albert Einstein College of Medicine. He is the principal investigator on research projects focusing on surgical education quality improvement. His work has been published in a number of peer-reviewed journals and books and has been presented nationally. In 2018, Dr. McAuliffe participated in the American College of Surgeons as Educators. He is board certified by the American Board of Surgery in General Surgery and Complex General Surgical Oncology and is a member of numerous professional societies, including the Society of Surgical Oncology, Society of Surgery of the Alimentary Tract, the American Society of Clinical Oncology, and the North American Neuroendocrine Tumor Society. Dr. Mcauliffe is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pheochromocytoma, Hereditary Paraganglioma-Pheochromocytoma Syndrome, Adrenal Gland Adenoma, Gallbladder Removal, and Gastrectomy.

Sun Young Oh, MD, is an Oncologist and Assistant Professor, Oncology and Medicine at Montefiore Einstein. Her clinical focus is on medical oncology and the systemic treatment of breast cancer. Dr. Oh is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

I am a board certified medical oncologist treating all solid tumor malignancies,with special expertise in gastrointestinal malignancies, gynecological malignancies and head and neck cancer. I am the Director of GI Malignancies for the Eastern Region at Northwell Health Cancer Institute, and Chief of Hematology Oncology at Huntington Hospital. I collaborate with a multidisciplinary team of physicians, surgeons, radiation oncologists, pathologists, and radiologists to bring the best possible care to patients who wish to be treated close to home on Long Island. I am also an attending physician of the Don Monti Division of Medical Oncology and Hematology at North Shore University Hospital, Long Island Jewish Medical Center and Southside Hospital. Prior to joining Northwell Health, I was an attending physician at Memorial Sloan Kettering Cancer Center. I completed my Internal Medicine residency training at Maimonides Medical Center and my fellowship in Hematology and Oncology at the University of Vermont. In addition to my work as a clinician, I have a strong interest in clinical research. I immensely enjoy teaching and have mentored many young physicians during their training. I am proud to be part of a dedicated multidisciplinary team, providing state- of-the-art comprehensive care to all of our patients on Long Island. Dr. Siebel is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Merkel Cell Carcinoma, and Lynch Syndrome. Dr. Siebel is board certified in American Board Of Internal Medicine/Medical Oncology.

Hersch Pachter is a General Surgeon practicing medicine in New York, New York. Dr. Pachter is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Gallbladder Disease, Gallstones, Choledocholithiasis, Small Bowel Resection, and Pancreatectomy. Dr. Pachter is board certified in American Board Of Surgery.

Brian Untch is a Surgical Oncologist and a General Surgeon practicing medicine in New York, New York. Dr. Untch is rated as an Advanced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Medullary Thyroid Carcinoma, Thyroid Cancer, Thyroid Nodule, Pancreaticoduodenectomy, and Thyroidectomy. Dr. Untch is currently accepting new patients.

Brendan Finnerty is a General Surgeon practicing medicine in New York, New York. Dr. Finnerty is rated as an Advanced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Gastroesophageal Reflux Disease (GERD), Diaphragmatic Hernia, Thyroidectomy, and Parathyroidectomy. Dr. Finnerty is currently accepting new patients.

Gastro-Intestinal Cancer. Dr. Kaubisch is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Ampullary Cancer.